RESUMO
BACKGROUND: Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood. We aimed to identify novel biochemical factors for prostate cancer incidence and mortality in UK Biobank. METHODS: A range of cardiovascular, bone, joint, diabetes, renal and liver-related biomarkers were measured in baseline blood samples collected from up to 211,754 men at recruitment and in a subsample 5 years later. Participants were followed-up via linkage to health administrative datasets to identify prostate cancer cases. Hazard ratios (HRs) and 95% confidence intervals were calculated using multivariable-adjusted Cox regression corrected for regression dilution bias. Multiple testing was accounted for by using a false discovery rate controlling procedure. RESULTS: After an average follow-up of 6.9 years, 5763 prostate cancer cases and 331 prostate cancer deaths were ascertained. Prostate cancer incidence was positively associated with circulating vitamin D, urea and phosphate concentrations and inversely associated with glucose, total protein and aspartate aminotransferase. Phosphate and cystatin-C were the only biomarkers positively and inversely, respectively, associated with risk in analyses excluding the first 4 years of follow-up. There was little evidence of associations with prostate cancer death. CONCLUSION: We found novel associations of several biomarkers with prostate cancer incidence. Future research will examine associations by tumour characteristics.
Assuntos
Biomarcadores Tumorais/sangue , Biomarcadores Tumorais/urina , Neoplasias da Próstata/epidemiologia , Adulto , Idoso , Aspartato Aminotransferases/sangue , Aspartato Aminotransferases/urina , Glicemia/análise , Proteínas Sanguíneas/análise , Proteínas Sanguíneas/urina , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/urina , Cistatina C/sangue , Seguimentos , Glicosúria , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Fosfatos/sangue , Fosfatos/urina , Estudos Prospectivos , Neoplasias da Próstata/sangue , Neoplasias da Próstata/mortalidade , Neoplasias da Próstata/urina , Fatores de Tempo , Reino Unido/epidemiologia , Ureia/sangue , Ureia/urina , Vitamina D/sangue , Vitamina D/urinaRESUMO
Protein N-glycosylation plays crucial roles in many biological processes and has close association with the occurrence and development of various cancers. Therefore, it is necessary to analyze the abnormal changes of N-glycopeptides in complex biological samples for biomarker discovery. However, due to their low abundance and poor ionization, N-glycopeptides identification in complex samples by mass spectrometry (MS) is still a challenging task. In this work, a novel magnetic hydrophilic material was prepared by serial functionalization of ultra-thin two-dimensional molybdenum disulfide with Fe3O4 nanoparticles, gold nanowire and glutathione (MoS2-Fe3O4-Au/NWs-GSH) for efficient N-glycopeptides enrichment. The advantage of using the new nanocomposite is threefold. First, the introduction of magnetic Fe3O4 nanoparticles efficiently simplifies the enrichment process. Second, the gold nanowire modification enlarges the surface area of the nanocomposites to facilitate interaction with N-glycopeptides. Third, the employment of highly hydrophilic glutathione leads to specific HILIC-based retention of N-glycopeptides. Low femtomolar detection sensitivity and 1:1000 enrichment selectivity can be achieved using MoS2-Fe3O4-Au/NWs-GSH enrichment and bio-mass spectrometry analysis. Successful applications in human urine exosome and serum proteins were demonstrated by the enrichment and identification of 1250 and 489â¯N-glycopeptides, respectively. This remarkable data set of N-glycoproteome indicates the application potential of the novel nanocomposites for N-glycopeptides enrichment in complex biological samples and for related glycoproteome studies.
Assuntos
Proteínas Sanguíneas/urina , Dissulfetos/química , Exossomos/química , Glutationa/química , Glicopeptídeos/química , Nanopartículas de Magnetita/química , Molibdênio/química , Cromatografia Líquida de Alta Pressão , Humanos , Interações Hidrofóbicas e HidrofílicasRESUMO
This study identified urinary biomarkers for tuberculosis (TB) diagnosis. The urine proteomic profiles of 45 pulmonary tuberculosis patients prior to anti-TB treatment and 45 healthy controls were analyzed and compared using two-dimensional electrophoresis with matrix-assisted laser desorption/ionization time of flight mass spectrometry. Nineteen differentially expressed proteins were identified preliminarily, and western blotting and qRT-PCR were performed to confirm these changes at the translational and transcriptional levels, respectively, using samples from 122 additional pulmonary tuberculosis patients and 73 additional healthy controls. Two proteins, mannose-binding lectin 2 and a 35-kDa fragment of inter-α-trypsin inhibitor H4, exhibited the highest differential expression. We constructed a protein-microRNA interaction network that primarily involved complement and inflammatory responses. Eleven microRNAs from microRNA-target protein interactions were screened and validated using qRT-PCR with some of the above samples, including 97 pulmonary tuberculosis patients and 48 healthy controls. Only miR-625-3p exhibited significant differential expression (p < 0.05). miR-625-3p was increased to a greater extent in samples of smear-positive than smear-negative patients. miR-625-3p was predicted to target mannose-binding lectin 2 protein. A binary logistic regression model based on miR-625-3p, mannose-binding lectin 2, and inter-α-trypsin inhibitor H4 was further established. This three-biomarker combination exhibited better performance for tuberculosis diagnosis than individual biomarkers or any two-biomarker combination and generated a diagnostic sensitivity of 85.87% and a specificity of 87.50%. These novel urine biomarkers may significantly improve tuberculosis diagnosis.
Assuntos
Biomarcadores/urina , MicroRNAs/urina , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/urina , Proteínas Sanguíneas/urina , Eletroforese em Gel Bidimensional , Feminino , Glicoproteínas/urina , Humanos , Masculino , Lectina de Ligação a Manose/urina , Pessoa de Meia-Idade , Proteínas Secretadas Inibidoras de Proteinases/urina , Proteômica/métodos , Sensibilidade e Especificidade , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Tuberculose Pulmonar/microbiologiaRESUMO
Asymptomatic bacteriuria (ABU) is highly prevalent among elderly patients. It can be difficult to distinguish ABU from symptomatic urinary tract infection (UTI) in this population, which leads to unnecessary antibiotic treatment. Urinary heparin-binding protein (U-HBP) and urinary interleukin-6 (U-IL-6) have previously been studied as diagnostic markers for UTI. In this study, biomarkers were measured in the urine of 134 nursing home residents. The prevalence of ABU in this population, excluding patients with urinary catheter, was 32.8%. Levels of U-HBP and IL-6 were significantly lower among residents with ABU when compared to 49 patients with verified UTI. When previously defined cut-off limits were used, U-HBP had a high negative predictive value for UTI (93%), however, the specificity for differentiating patients with UTI and ABU was low. Discriminatory values were better for U-IL-6 with a sensitivity of 80% and specificity of 82% for the differentiation between the subgroup of pyelonephritis and ABU.
Assuntos
Peptídeos Catiônicos Antimicrobianos/urina , Bacteriúria/diagnóstico , Biomarcadores/urina , Proteínas Sanguíneas/urina , Proteínas de Transporte/urina , Interleucina-6/urina , Infecções Urinárias/diagnóstico , Idoso de 80 Anos ou mais , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Valor Preditivo dos Testes , Sensibilidade e EspecificidadeRESUMO
UNLABELLED: Timely antibiotic initiation for acute pyelonephritis (APN) can prevent renal complications. We investigated whether urine heparin binding protein (UHBP), a cytokine released from activated neutrophils, was a useful diagnostic tool for APN. Febrile children with presumed APN were prospectively enrolled between January and September 2013, and divided into two groups based on urine cultures. UHBP levels were measured at enrollment in all children and 1 month after antibiotic treatment in children with APN. UHBP levels in children with APN at baseline and 1 month versus controls were 47.0 ± 8.4 and 16.6 ± 3.8 vs. 15.0 ± 2.9 ng/mL, respectively (p < 0.001). Test performance characteristics were calculated against a gold standard of positive urine cultures and compared with leukocyte esterase (LE) and nitrite measured by dipsticks and pyuria by microscopy. The sensitivity and specificity for UHBP levels ≥34 ng/mL were 100 and 100 %. Spearman's rank coefficient was used to assess the associations between routine laboratory tests and UHBP levels. Significant positive correlations were found with pyuria grade (Spearman's rho = 0.62; p < 0.001), neutrophil count (rho = 0.38; p = 0.03), and platelet count (rho = 0.39; p = 0.03). CONCLUSIONS: UHBP is a valid adjunctive diagnostic tool for aiding clinicians in making rapid treatment decisions for APN.
Assuntos
Peptídeos Catiônicos Antimicrobianos/urina , Proteínas Sanguíneas/urina , Proteínas de Transporte/urina , Pielonefrite/diagnóstico , Adolescente , Hidrolases de Éster Carboxílico/urina , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática , Feminino , Taxa de Filtração Glomerular , Humanos , Lactente , Contagem de Leucócitos , Masculino , Neutrófilos/citologia , Nitritos/urina , Estudos Prospectivos , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
The most important of nature of biomarker is changes. Blood is under strict homeostatic control which means changes tend to be removed from blood. Urine is a partial filtrate of blood, reflects systemic physiology but with no homeostatic mechanism. However, changes induced directly into the blood can be more sensitively detected in urine than in blood itself. This indicates that urine may serve as a source for more sensitive detection of protein biomarkers than blood.
Assuntos
Biomarcadores/sangue , Biomarcadores/urina , Proteínas Sanguíneas/urina , Proteômica/métodos , Animais , Anticoagulantes/farmacologia , Arginina/análogos & derivados , Cromatografia Líquida , Feminino , Heparina/farmacologia , Humanos , Ácidos Pipecólicos/farmacologia , Proteoma/análise , Proteoma/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Sulfonamidas , Espectrometria de Massas em TandemRESUMO
BACKGROUND: The recent evolution of genomics and subsequently proteomics offers a major advance in the ability to understand individual human variation in disease and the molecular level changes induced by certain environmental exposures. This original study examines urinary proteome composition to enable the understanding of molecular homeostatic mechanisms in spaceflight and presents the potential for early detection of subclinical disease, microgravity risk mitigation strategies, and countermeasure development for exploration-class missions. METHODS: The urinary proteome composition of six Russian cosmonauts (men, ages 35-51) who flew long-duration missions of 169-199 d was determined 30 d before flight and compared to repeat studies 1 and 7 d postflight. RESULTS: There were 430 proteins identified. Of those, 15 proteins originated in the renal tissues. Of the 15 urinary proteins, 10 were consistently present in the urine. However, the presence of five of the urinary proteins--neutral endopeptidase (NEP), afamin (AFAM), aquaporin-2 (AQP2), aminopeptidase A (AMPE), and dipeptidyl peptidase 4 (DPP4)--was dependent on spaceflight exposure. DISCUSSION: Proteomic investigation of pre- and postflight urine and bioinformation approaches to proteome analysis provide important data relative the mechanism of kidney function in spaceflight. In this initial study, we determined that the evaluation of urinary proteins may help investigators understand changes that are occurring in microgravity. Once additional ground-based and in-flight data are collected, it is feasible to develop targeted studies for tracking specific spaceflight related changes, determine countermeasure and risk-mitigation effectiveness, and possibly detect subclinical disease in flight crewmembers.
Assuntos
Voo Espacial , Adulto , Aquaporina 2/urina , Proteínas Sanguíneas/urina , Proteínas de Transporte/urina , Cromatografia Líquida , Dipeptidil Peptidase 4/urina , Fator de Crescimento Epidérmico/urina , Glutamil Aminopeptidase/urina , Glicoproteínas/urina , Humanos , Cininogênios/urina , Proteína-2 Relacionada a Receptor de Lipoproteína de Baixa Densidade/análise , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade , Neprilisina/urina , Osteopontina/urina , Receptores de Superfície Celular/análise , Albumina Sérica , Albumina Sérica Humana , Calicreínas Teciduais/urina , Uromodulina/urina , Molécula 1 de Adesão de Célula Vascular/urina , beta-Defensinas/urinaRESUMO
BACKGROUND: Urinary tract infection (UTI) is a common infection diagnosis in children, and efficient diagnosis and treatment are important to avoid serious complications. In this study we investigated whether urinary levels of neutrophil-derived heparin-binding protein (HBP) can be used as a marker of UTI in children. These results were compared to those of dipstick analysis, interleukin-6 (IL-6) analysis in urine, and bacterial culturing. METHODS: Seventy-eight children aged 0-18 years with fever and/or symptoms indicating UTI were enrolled in a prospective consecutive study. Urine samples were cultured and analyzed with dipstick, and concentrations of HBP and IL-6 were measured. RESULTS: Fifteen patients were classified as having UTI, 30 patients had fever but were diagnosed with a non-urinary tract infection, and 33 patients had neither UTI nor fever. Using a urine HBP (U-HBP) cut-off level of 32 ng/mL, the sensitivity and specificity for detecting UTI were 93.3 and 90.3 %, respectively. Receiver operating characteristic curves demonstrated that U-HBP levels were a higher specificity indicator of UTI than urine white blood cell counts or urine IL-6 levels; they also showed a higher sensitivity than the results of the urine nitrite test. All patients with significant growth of clinically relevant bacteria had elevated U-HBP levels. CONCLUSION: The results indicate that rapid analysis of U-HBP can provide helpful guidance in the management of children with suspected UTI.
Assuntos
Peptídeos Catiônicos Antimicrobianos/urina , Proteínas Sanguíneas/urina , Proteínas de Transporte/urina , Infecções Urinárias/urina , Adolescente , Biomarcadores/urina , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Lactente , Masculino , Estudos Prospectivos , Curva ROC , Sensibilidade e EspecificidadeAssuntos
Cardiomegalia/diagnóstico por imagem , Mieloma Múltiplo/diagnóstico , Edema Pulmonar/diagnóstico por imagem , Insuficiência Renal/diagnóstico , Idoso de 80 Anos ou mais , Eletroforese das Proteínas Sanguíneas , Proteínas Sanguíneas/urina , Medula Óssea/patologia , Cardiomegalia/etiologia , Feminino , Humanos , Cadeias Leves de Imunoglobulina/sangue , Imunoglobulinas/sangue , Mieloma Múltiplo/complicações , Edema Pulmonar/etiologia , Radiografia , Insuficiência Renal/etiologiaAssuntos
Biomarcadores/sangue , Biomarcadores/urina , Úlcera por Pressão/sangue , Úlcera por Pressão/urina , Traumatismos da Medula Espinal/sangue , Traumatismos da Medula Espinal/urina , Animais , Proteínas Sanguíneas/urina , Modelos Animais de Doenças , Proteínas de Ligação a Ácido Graxo/sangue , Proteínas de Ligação a Ácido Graxo/urina , Feminino , Glicoproteínas/sangue , Glicoproteínas/urina , Mioglobina/sangue , Mioglobinúria/etiologia , Miosinas/sangue , Miosinas/urina , Orosomucoide , Ratos , Ratos Sprague-Dawley , Troponina I/sangue , Troponina I/urinaRESUMO
Previous studies of diabetic patients indicate that increased urinary excretion of certain plasma proteins (molecular radii <55 A), such as IgG, transferrin, and ceruloplasmin, precede the development of microalbuminuria. Moreover, increases in these urinary proteins predict future development of microalbuminuria. To clarify whether blood pressure changes influence urinary excretion of these proteins, we examined relationships between diurnal blood pressure changes measured by ambulatory blood pressure monitoring and urinary excretion of IgG, transferrin, ceruloplasmin, alpha2-macroglobulin (88 A) and albumin (36 A) measured separately during the day and night in 20 healthy controls and 26 normotensive, normoalbuminuric diabetic patients. Diurnal change in systolic blood pressure was not correlated to urinary excretion of either albumin or alpha2-macroglobulin in either diabetic patients or controls. However, statistically significant correlations between diurnal changes in systolic blood pressure and those of urinary excretion of IgG, transferrin and ceruloplasmin were found in diabetic patients but not in controls. The present findings suggest that urinary excretion of IgG, transferrin, and ceruloplasmin are more easily affected than albuminuria by systemic blood pressure changes in normoalbuminuric diabetic patients. This is supported by our previous finding that urinary excretion of IgG, transferrin and ceruloplasmin increased while albuminuria did not following enhanced glomerular filtration rate after acute protein loading, which causes increased glomerular capillary pressure due to afferent arterioles dilation, mimicking diabetic intra-renal hemodynamics. Taken together, these findings suggest that urinary excretion of IgG, transferrin, and ceruloplasmin may be more sensitive indicators of glomerular capillary pressure change than albuminuria in normoalbuminuric diabetic patients.
Assuntos
Pressão Sanguínea/fisiologia , Ceruloplasmina/urina , Ritmo Circadiano/fisiologia , Diabetes Mellitus Tipo 2/fisiopatologia , Diabetes Mellitus Tipo 2/urina , Imunoglobulina G/urina , Transferrina/urina , Adulto , Idoso , Albuminúria/urina , Proteínas Sanguíneas/urina , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
We sought to identify a new serum biomarker for breast cancer screening and diagnosis using stepwise proteomic analysis of sera from breast cancer patients to detect the presence of autoantibodies that react with urinary protein. Two-dimensional immunoblotting was done for screening autoimmunogenic tumor antigens in the urine of breast cancer patients. Reactive spots were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Among urinary proteins separated by two-dimensional electrophoresis, 13 spots showed strong reactivity with pooled sera from breast cancer patients or control sera. By mass spectrometry, we identified alpha 2-HS glycoprotein (AHSG) as a tumor antigen. Peripheral blood was obtained from 81 women diagnosed with breast cancer before surgery and 73 female donors without evidence of any malignancy for the individual analysis. In one-dimensional Western blot analysis, AHSG autoantibody was detected in 64 of 81 breast cancer patients (79.1%) and in 7 of 73 controls (9.6%). The sensitivity of this test in breast cancer patients was 79.0%. Our results suggest that AHSG and anti-AHSG autoantibody may be useful serum biomarkers for breast cancer screening and diagnosis.
Assuntos
Antígenos de Neoplasias/sangue , Biomarcadores Tumorais/sangue , Proteínas Sanguíneas/metabolismo , Neoplasias da Mama/diagnóstico , Adulto , Antígenos de Neoplasias/urina , Biomarcadores Tumorais/urina , Proteínas Sanguíneas/urina , Western Blotting , Neoplasias da Mama/sangue , Neoplasias da Mama/urina , Detecção Precoce de Câncer , Eletroforese em Gel Bidimensional , Feminino , Humanos , Técnicas Imunoenzimáticas , Pessoa de Meia-Idade , Curva ROC , Sensibilidade e Especificidade , alfa-2-Glicoproteína-HSRESUMO
BACKGROUND: Because of the risk of performing renal biopsies in children with co-morbid conditions, we carried out this study to identify candidate protein biomarkers in the urine of HIV-infected children with renal disease. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: Urine samples from HIV-infected children with biopsy proven HIV-nephropathy (HIVAN; n = 4), HIV-associated Hemolytic Uremic Syndrome (HIV-HUS; n = 2), or no renal disease (n = 3) were analyzed by two-dimensional electrophoresis (2-DE) and proteomic methods. Positive findings were confirmed in HIV-infected children with (n = 20) and without (n = 10) proteinuria using commercially available assays. RESULTS: By 2-DE analysis, a single urine marker was not sufficient to distinguish children with HIVAN from the others. High urine levels of beta(2)-microglobulin and retinol-binding protein (RBP) suggested the presence of tubular injury. In addition, we found elevated urine levels of iron and the iron-related proteins, transferrin, hemopexin, haptoglobin, lactoferrin, and neutrophil gelatinase-associated lipocalin (NGAL), in children with HIVAN and HIV-HUS. Furthermore, we detected a significant accumulation of iron in the urine and kidneys of HIV-transgenic (Tg) rats with renal disease. CONCLUSION: These findings suggest that iron and iron-related proteins might be promising candidate urine biomarkers to identify HIV-infected children at risk of developing HIVAN and HIV-HUS. Moreover, based on the results of previous studies, we speculate that the release or accumulation of iron in the kidney of HIV-infected children may contribute to the rapid progression of their renal disease, and could become a new therapeutic target against HIVAN and HIV-HUS.
Assuntos
Nefropatia Associada a AIDS/urina , Proteínas Sanguíneas/urina , Infecções por HIV/virologia , HIV-1/patogenicidade , Síndrome Hemolítico-Urêmica/urina , Proteinúria/urina , Nefropatia Associada a AIDS/patologia , Nefropatia Associada a AIDS/virologia , Proteínas de Fase Aguda/urina , Animais , Biomarcadores/urina , Biópsia , Estudos de Casos e Controles , Modelos Animais de Doenças , Infecções por HIV/complicações , Infecções por HIV/patologia , Infecções por HIV/urina , HIV-1/genética , Haptoglobinas/urina , Síndrome Hemolítico-Urêmica/patologia , Síndrome Hemolítico-Urêmica/virologia , Hemopexina/urina , Humanos , Ferro/urina , Lactoferrina/urina , Lipocalina-2 , Lipocalinas/urina , Valor Preditivo dos Testes , Proteinúria/virologia , Proteínas Proto-Oncogênicas/urina , Ratos , Ratos Transgênicos , Fatores de Tempo , Transferrina/urinaRESUMO
Lupus nephritis (LN) is among the main determinants of poor prognosis in systemic lupus erythematosus (SLE). The objective of this study was to 1) isolate and identify proteins contained in the LN urinary protein signature (PS) of children with SLE; 2) assess the usefulness of the PS proteins for detecting activity of LN over time. Using surface-enhanced or matrix-assisted laser desorption/ionization time of flight mass spectrometry, the proteins contained in the LN urinary PS were identified. They were transferrin (Tf), ceruloplasmin (Cp), alpha1-acid-glycoprotein (AGP), lipocalin-type prostaglandin-D synthetase (L-PGDS), albumin, and albumin-related fragments. Serial plasma and urine samples were analyzed using immunonephelometry or ELISA in 98 children with SLE (78% African American) and 30 controls with juvenile idiopathic arthritis. All urinary PS proteins were significantly higher with active vs. inactive LN or in patients without LN (all p < 0.005), and their combined area under the receiver operating characteristic curve was 0.85. As early as 3 mo before a clinical diagnosis of worsening LN, significant increases of urinary Tf, AGP (both p < 0.0001), and L-PGDS (p < 0.01) occurred, indicating that these PS proteins are biomarkers of LN activity and may help anticipate the future course of LN.
Assuntos
Proteínas Sanguíneas/urina , Lúpus Eritematoso Sistêmico/diagnóstico , Nefrite Lúpica/diagnóstico , Proteinúria/diagnóstico , Adolescente , Albuminúria/diagnóstico , Artrite Juvenil/diagnóstico , Artrite Juvenil/urina , Biomarcadores/sangue , Biomarcadores/urina , Estudos de Casos e Controles , Ceruloplasmina/urina , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Oxirredutases Intramoleculares/sangue , Oxirredutases Intramoleculares/urina , Lipocalinas/sangue , Lipocalinas/urina , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/urina , Nefrite Lúpica/etiologia , Nefrite Lúpica/urina , Masculino , Nefelometria e Turbidimetria , Orosomucoide/urina , Valor Preditivo dos Testes , Prognóstico , Proteinúria/etiologia , Proteinúria/urina , Curva ROC , Reprodutibilidade dos Testes , Albumina Sérica/metabolismo , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Fatores de Tempo , Transferrina/urinaRESUMO
OBJECTIVE: The purpose of this study was to identify differences in urine proteins between patients with interstitial cystitis (IC) and asymptomatic control (AC) subjects with the use of proteomic techniques. STUDY DESIGN: Nine patients with IC and their age-, race-, and sex-matched AC subjects volunteered a urine specimen. Urine proteins were separated with the use of 2-dimensional polyacrylamide gels. Differing proteins underwent digestion and matrix-assisted laser desorption ionization-time of flight mass spectrometry. Computer-assisted data analysis was used to identify the corresponding protein. Differences in urine protein responses between patients with IC and AC subjects were evaluated by the Mann-Whitney U test to account for the nonnormal frequency distribution of the parameter estimate or chi-square when data were bimodal. RESULTS: Four proteins differed significantly between patients with IC and AC subjects. The AC subjects had a greater concentration of a uromodulin (P = .019) and two kininogens (P = .023, .046). The patients with IC had a greater concentration of inter-alpha-trypsin inhibitor heavy chain H4 (P = .019). CONCLUSION: These urine protein isoforms may be biomarkers for IC.
Assuntos
Cistite Intersticial/diagnóstico , Proteínas/análise , Proteômica , Urina/química , Adolescente , Adulto , Idoso , alfa-Globulinas/urina , Biomarcadores/urina , Proteínas Sanguíneas/urina , Cistite Intersticial/urina , Diagnóstico Diferencial , Eletroforese em Gel de Poliacrilamida , Feminino , Glicoproteínas/urina , Humanos , Cininogênios/urina , Masculino , Pessoa de Meia-Idade , Mucoproteínas/urina , Isoformas de Proteínas , Proteínas Secretadas Inibidoras de Proteinases/urina , Qualidade de Vida , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , UromodulinaRESUMO
Current methods in the noninvasive detection and surveillance of bladder cancer via urine analysis include voided urine cytology (VUC) and some diagnostic urinary protein biomarkers; however, due to the poor sensitivity of VUC and high false-positive rates of currently available protein assays, detection of bladder cancer via urinalysis remains a challenge. In the study presented here, a rapid, high-sensitivity technique was developed to profile the N-linked glycoprotein component in naturally micturated human urine specimens. Concanavalin A (Con A) affinity chromatography coupled to nanoflow liquid chromatography was utilized to separate the complex peptide mixture prior to a linear ion trap MS analysis. Of 186 proteins identified with high confidence by multiple analyses, 40% were secreted proteins, 18% membrane proteins, and 14% extracellular proteins. In this study, the presence of several proteins appeared to be associated with the presence of bladder cancer, including alpha-1B-glycoprotein that was detected in all tumor-bearing patient samples but in none of the samples obtained from non-tumor-bearing individuals. The combination of Con A affinity chromatography and nano-LC/MS/MS provides an initial investigation of N-glycoproteins in complex biological samples and facilitates the identification of potential biomarkers of bladder cancer in noninvasively obtained human urine.
Assuntos
Biomarcadores Tumorais/urina , Proteínas Sanguíneas/urina , Glicoproteínas/urina , Imunoglobulinas/urina , Proteômica/métodos , Urinálise/métodos , Neoplasias da Bexiga Urinária/urina , Sequência de Aminoácidos , Cromatografia de Afinidade/métodos , Cromatografia Líquida/métodos , Concanavalina A/química , Humanos , Espectrometria de Massas , Dados de Sequência Molecular , Nanotecnologia/métodos , Análise Serial de Proteínas/métodosRESUMO
Serum-free light chain (SFLC) levels are useful for diagnosing nonsecretory myeloma and monitoring response in light-chain-only disease, especially in the presence of renal failure. As part of a tandem autotransplantation trial for newly diagnosed multiple myeloma, SFLC levels were measured at baseline, within 7 days of starting the first cycle, and before both the second induction cycle and the first transplantation. SFLC baseline levels higher than 75 mg/dL (top tertile) identified 33% of 301 patients with higher near-complete response rate (n-CR) to induction therapy (37% vs 20%, P = .002) yet inferior 24-month overall survival (OS: 76% vs 91%, P < .001) and event-free survival (EFS: 73% vs 90%, P < .001), retaining independent prognostic significance for both EFS (HR = 2.40, P = .008) and OS (HR = 2.43, P = .016). Baseline SFLC higher than 75 mg/dL was associated with light-chain-only secretion (P < .001), creatinine level 176.8 microM (2 mg/dL) or higher (P < .001), beta-2-microglobulin 297.5 nM/L (3.5 mg/L) or higher (P < .001), lactate dehydrogenase 190 U/L or higher (P < .001), and bone marrow plasmacytosis higher than 30% (P = .003). Additional independent adverse implications were conferred by top-tertile SFLC reductions before cycle 2 (OS: HR = 2.97, P = .003; EFS: HR = 2.56, P = .003) and before transplantation (OS: HR = 3.31, P = .001; EFS: HR = 2.65, P = .003). Unlike baseline and follow-up analyses of serum and urine M-proteins, high SFLC levels at baseline-reflecting more aggressive disease-and steeper reductions after therapy identified patients with inferior survival.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Biomarcadores Tumorais/sangue , Biomarcadores Tumorais/urina , Cadeias Leves de Imunoglobulina/sangue , Cadeias Leves de Imunoglobulina/urina , Mieloma Múltiplo/sangue , Mieloma Múltiplo/urina , Transplante de Células-Tronco , Adulto , Idoso , Idoso de 80 Anos ou mais , Proteínas Sanguíneas/análise , Proteínas Sanguíneas/urina , Medula Óssea/patologia , Ácidos Borônicos/administração & dosagem , Bortezomib , Cisplatino/administração & dosagem , Creatinina/sangue , Creatinina/urina , Dexametasona/administração & dosagem , Intervalo Livre de Doença , Doxorrubicina/administração & dosagem , Etoposídeo/administração & dosagem , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/complicações , Mieloma Múltiplo/mortalidade , Mieloma Múltiplo/patologia , Mieloma Múltiplo/terapia , Pirazinas/administração & dosagem , Insuficiência Renal/sangue , Insuficiência Renal/etiologia , Insuficiência Renal/mortalidade , Insuficiência Renal/patologia , Insuficiência Renal/terapia , Insuficiência Renal/urina , Taxa de Sobrevida , Talidomida/administração & dosagem , Transplante AutólogoRESUMO
Human eosinophil granule major basic protein (MBP1) is an exceedingly basic (isoelectric point >11) 14-kDa protein, comprising the core of the secondary eosinophil granule. Recently, a less cationic homolog of MBP, termed MBPH or simply, MBP2, has been discovered. We prepared a panel of mAbs to MBP2 and used these Abs to localize and quantitate this molecule in leukocytes and biological fluids. Specific mAbs for MBP2 were selected using slot-blot analyses and used in a two-site immunoassay, Western blotting, and immunofluorescence microscopy. The sensitivity of the immunoassay was markedly improved by reduction and alkylation of MBP2. MBP1 is more abundant than MBP2 in lysates of eosinophils and their granules, as judged by immunoassay and Western blotting. By immunofluorescence, MBP1 is present in eosinophils, basophils, and a human mast cell line (HMC1), whereas MBP2 is only detected in eosinophils. Neither MBP1 nor MBP2 could be detected in any other peripheral blood leukocyte. MBP2 levels measured in plasma and serum were essentially identical. In contrast to past measurements for MBP1, MBP2 was not detected above normal levels in sera from pregnant donors. However, measurement of serum MBP2 discriminated patients with elevated eosinophils from normal subjects, and MBP2 was also detectable in other biological specimens, such as bronchoalveolar lavage, sputum, and stool. These results indicate that MBP2 is present only in eosinophils and that it may be a useful biomarker for eosinophil-associated diseases.
Assuntos
Eosinófilos/química , Proteoglicanas/sangue , Anticorpos Monoclonais/metabolismo , Especificidade de Anticorpos , Biomarcadores/sangue , Biomarcadores/química , Biomarcadores/urina , Proteínas Sanguíneas/imunologia , Proteínas Sanguíneas/isolamento & purificação , Proteínas Sanguíneas/urina , Proteína Básica Maior de Eosinófilos , Eosinofilia/sangue , Fezes/química , Feminino , Humanos , Imunoensaio , Gravidez , Proteínas da Gravidez/sangue , Proteínas da Gravidez/urina , Proteoglicanas/imunologia , Proteoglicanas/isolamento & purificação , Proteoglicanas/urina , Homologia Estrutural de ProteínaRESUMO
Urinary exosomes containing apical membrane and intracellular fluid are normally secreted into the urine from all nephron segments, and may carry protein markers of renal dysfunction and structural injury. We aimed to discover biomarkers in urinary exosomes to detect acute kidney injury (AKI), which has a high mortality and morbidity. Animals were injected with cisplatin. Urinary exosomes were isolated by differential centrifugation. Protein changes were evaluated by two-dimensional difference in gel electrophoresis and changed proteins were identified by mass spectrometry. The identified candidate biomarkers were validated by Western blotting in individual urine samples from rats subjected to cisplatin injection; bilateral ischemia and reperfusion (I/R); volume depletion; and intensive care unit (ICU) patients with and without AKI. We identified 18 proteins that were increased and nine proteins that were decreased 8 h after cisplatin injection. Most of the candidates could not be validated by Western blotting. However, exosomal Fetuin-A increased 52.5-fold at day 2 (1 day before serum creatinine increase and tubule damage) and remained elevated 51.5-fold at day 5 (peak renal injury) after cisplatin injection. By immunoelectron microscopy and elution studies, Fetuin-A was located inside urinary exosomes. Urinary Fetuin-A was increased 31.6-fold in the early phase (2-8 h) of I/R, but not in prerenal azotemia. Urinary exosomal Fetuin-A also increased in three ICU patients with AKI compared to the patients without AKI. We conclude that (1) proteomic analysis of urinary exosomes can provide biomarker candidates for the diagnosis of AKI and (2) urinary Fetuin-A might be a predictive biomarker of structural renal injury.